How high breast cancer rates hyperplasia?

Most of lobular hyperplasia is not cancerous. It is worth noting that sometimes is difficult to diagnose, the early diagnosis of lobular breast cancer and delay in treatment, more cases will be diagnosed as lobular carcinoma, which led to the patient's psychological stress and anxiety.

In short, lobular breast common diseases, should be regular follow-up, symptoms should be given appropriate treatment, follow-up should pay attention and breast cancer identification.

Breast lobular hyperplasia is a symptom of breast disease by a common cause, the higher the incidence of mammary glands, most women are likely to suffer from breast lobular hyperplasia. Cause breast lobular hyperplasia have generated a lot of the main reason is that endocrine disorders or mental emotional and other factors. Female estrogen excess, lack of decomposition, leading to endocrine disorders, may also cause breast cancer.

Breast lobular hyperplasia neither inflammation nor tumor, normal tissue is a physiological disorder breast tissue proliferation and subinvolution result, the performance of the menstrual cycle-related breast tenderness, may also have ill-defined mass, usually with the menstrual cycle changes subsided.

This is a common disease, 70% -80% of women have had. General obvious symptoms without treatment, for patients with more severe pain may be appropriate medication under the guidance of the physician. Clinical shows that only 1% of lobular malignant transformation occurs, women should not be overly worried.
Emotional instability, feeling uncomfortable, overwork, sexual disharmony, living environment changes, or overeating tonics and long-term use of cosmetics containing hormones contain hormones ingredients, etc., can affect the human estrogen and progesterone imbalance or secretion rhythm disturbance caused by breast tissue.

It found that after suffering common breast disease should be treated in a timely manner to control the disease and prevent further deterioration of development, review breast infrared scan 1-2 times a year.